ArticleBone marrow transplantation2019

The use of bispecific antibodies to optimize the outcome of patients with acute leukemia, lymphoma and multiple myeloma after SCT.

Hermann Einsele et al.PubMed ↗Publisher ↗

No numbers read from the abstract.